Irma Bagdoniene on NEJM-Published VESALIUS-CV: 25% Fewer First CV Events
Irma Bagdoniene, Cardiologist and Lipidologist at Klinikum Lippe – University Hospital for Cardiology, Angiology, and Internal Intensive Care Medicine, posted on LinkedIn:
”VESALIUS-CV at AHA:
The Room Was Applauding – And Not Without Reason
Presented at the AHA Congress and now published in NEJM, VESALIUS-CV marks a turning point in preventive cardiology.
In patients without prior MI or stroke, evolocumab reduced first major cardiovascular events by 25% — safely and decisively.
LDL lowering works – and earlier intervention saves lives.
When an entire audience of cardiologists applauds, it’s not hype. It’s the sound of a paradigm shifting.”
Read the full article here.
Title: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
Authors: Erin A. Bohula, D.Phil., Nicholas A. Marston, Ajay K. Bhatia, Gaetano M. De Ferrari, Lawrence A. Leiter, Jose C. Nicolau, Jeong-Gun Park, Julia F. Kuder, Sabina A. Murphy, Emileigh Walsh, Huei Wang, Vladimir Blaha, Andrzej Budaj, Jan H. Cornel, Assen Goudev, Robert Gabor Kiss, Alberto J. Lorenzatti, Alexander Parkhomenko, Marcoli Cyrille, Gabriel Paiva da Silva Lima, E. Magnus Ohman, Robert P. Giugliano, Marc S. Sabatine
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
-
Aug 23, 2026, 10:10Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:03Balaji Balagani: Major Causes of Sudden Cardiac Death in Children
-
Aug 23, 2026, 16:02Bartosz Hudzik: What’s Hot at ESC Congress 2026
-
Aug 23, 2026, 16:01Jim Hoffman: NETs in STEMI and Their Association With PCI and Antithrombotic Treatments
-
Aug 23, 2026, 16:01Luis Oliverio Ambriz Garcia: Key Insights Into Myeloproliferative Neoplasms From the 2026 NEJM Review
-
Aug 23, 2026, 15:58Howard Smith: Automated MR Imaging Aids New Stroke Therapy Development